7-Allyl-8-(benzyloxy)-5-chloroquinoline

Catalog No.: 
ACAVAF777
CAS No.: 
1009842-68-5
Molecular Formula: 
C19H16ClNO
Molecular Weight: 
309.80
7-Allyl-8-(benzyloxy)-5-chloroquinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$174.00InquiryInquiry
1g95%$519.00InquiryInquiry
5g95%$2569.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Allyl-8-(benzyloxy)-5-chloroquinoline
IUPAC Name7-allyl-8-(benzyloxy)-5-chloroquinoline
Molecular FormulaC19H16ClNO
Molecular Weight309.80
SMILESClC1=C2C=CC=NC2=C(OCC3=CC=CC=C3)C(CC=C)=C1
InChI KeyQTWVOAJDZOBLJW-UHFFFAOYSA-N
Synonym7-Allyl-8-(benzyloxy)-5-chloroquinoline;Quinoline, 5-chloro-8-(phenylMethoxy)-7-(2-propen-1-yl)-
CAS No.1009842-68-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACAVAF777 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAVAF777 route product structure diagram
    ACAVAF7771009842-68-5
Inquiry

2. ACAVAF777 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAVAF777 route product structure diagram
    ACAVAF7771009842-68-5
Inquiry

3. ACAVAF777 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAVAF777 route product structure diagram
    ACAVAF7771009842-68-5
Inquiry

Comments (0)